Role for CD74 and CXCR4 in clathrin-dependent endocytosis of the cytokine MIF

European Journal of Cell Biology

Volumn 91, Issue 6-7, 2012, Pages 435-449

  Schwartz, Verena ^a   Krüttgen, Alexander ^a   Weis, Joachim ^a   Weber, Christian ^b   Ostendorf, Tammo ^a   Lue, Hongqi ^a   Bernhagen, Jürgen ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Arrestin; Chemokine; Cytokine; Dynamin; Endosomal signaling; G protein coupled receptor (GPCR); Heteromeric receptor complex; Inflammation; MIF receptor; Uptake

Indexed keywords

CD74 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CHLORPROMAZINE; CHOLERA TOXIN; CLATHRIN; CYTOKINE; DANSYLCADAVERINE; DYNAMIN; LOW DENSITY LIPOPROTEIN; MIGRATION INHIBITION FACTOR; PLERIXAFOR; PROTEIN KINASE B; TRANSFERRIN;

ACETYLATION; ACIDIFICATION; ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CELL STRAIN HEK293; ENDOCYTOSIS; ENDOSOME; HELA CELL; HUMAN; HUMAN CELL; MICROTUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CLATHRIN; CYTOKINES; ENDOCYTOSIS; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84860252668     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2011.08.006     Document Type: Article

References (65)

1. Berndt K., Kim M., Meinhardt A., Klug J. Macrophage migration inhibitory factor does not modulate co-activation of androgen receptor by Jab1/CSN5. Mol. Cell. Biochem. 2008, 307:265-271.
2. Bernhagen J., Krohn R., Lue H., Gregory J.L., Zernecke A., Koenen R.R., Dewor M., Georgiev I., Schober A., Leng L., Kooistra T., Fingerle-Rowson G., Ghezzi P., Kleemann R., McColl S.R., Bucala R., Hickey M.J., Weber C. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 2007, 13:587-596.
3. Bernhagen J., Mitchell R.A., Calandra T., Voelter W., Cerami A., Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration Inhibitory factor (MIF). Biochemistry 1994, 33:14144-14155.
4. Binsky I., Haran M., Starlets D., Gore Y., Lantner F., Harpaz N., Leng L., Goldenberg D.M., Shvidel L., Berrebi A., Bucala R., Shachar I. IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:13408-13413.
5. Borghese F., Clanchy F.I. CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease. Expert Opin. Ther. Targets 2011, 15:237-251.
6. Borroni E.M., Mantovani A., Locati M., Bonecchi R. Chemokine receptors intracellular trafficking. Pharmacol Ther 2010, 127:1-8.
7. Burger-Kentischer A., Goebel H., Seiler R., Fraedrich G., Schaefer H.E., Dimmeler S., Kleemann R., Bernhagen J., Ihling C. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 2002, 105:1561-1566.
8. Busch R., Rinderknecht C.H., Roh S., Lee A.W., Harding J.J., Burster T., Hornell T.M., Mellins E.D. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunol. Rev. 2005, 207:242-260.
9. Calandra T., Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 2003, 3:791-800.
10. Carpenter G., Cohen S. Epidermal growth factor. Annu. Rev. Biochem 1979, 48:193-216.
11. Cheng Z.J., Zhao J., Sun Y., Hu W., Wu Y.L., Cen B., Wu G.X., Pei G. Beta-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between beta-arrestin and CXCR4. J. Biol. Chem. 2000, 275:2479-2485.
12. Cho Y., Crichlow G.V., Vermeire J.J., Leng L., Du X., Hodsdon M.E., Bucala R., Cappello M., Gross M., Gaeta F., Johnson K., Lolis E.J. Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11313-11318.
13. Coleman A.M., Rendon B.E., Zhao M., Qian M.W., Bucala R., Xin D., Mitchell R.A. Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase. J. Immunol. 2008, 181:2330-2337.
14. Damke H., Baba T., Warnock D.E., Schmid S.L. Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J. Cell Biol. 1994, 127:915-934.
15. Dessein A.F., Stechly L., Jonckheere N., Dumont P., Monte D., Leteurtre E., Truant S., Pruvot F.R., Figeac M., Hebbar M., Lecellier C.H., Lesuffleur T., Dessein R., Grard G., Dejonghe M.J., de Launoit Y., Furuichi Y., Prevost G., Porchet N., Gespach C., Huet G. Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells. Cancer Res. 2010, 70:4644-4654.
16. DeWire S.M., Ahn S., Lefkowitz R.J., Shenoy S.K. Beta-arrestins and cell signaling. Annu. Rev. Physiol. 2007, 69:483-510.
17. Dickson R.B., Hanover J.A., Willingham M.C., Pastan I. Prelysosomal divergence of transferrin and epidermal growth factor during receptor-mediated endocytosis. Biochemistry 1983, 22:5667-5674.
18. Dunn K.W., McGraw T.E., Maxfield F.R. Iterative fractionation of recycling receptors from lysosomally destined ligands in an early sorting endosome. J. Cell Biol. 1989, 109:3303-3314.
19. Futahashi Y., Komano J., Urano E., Aoki T., Hamatake M., Miyauchi K., Yoshida T., Koyanagi Y., Matsuda Z., Yamamoto N. Separate elements are required for ligand-dependent and -independent internalization of metastatic potentiator CXCR4. Cancer Sci 2007, 98:373-379.
20. Ghosh R.N., Gelman D.L., Maxfield F.R. Quantification of low density lipoprotein and transferrin endocytic sorting HEp2 cells using confocal microscopy. J. Cell Sci. 1994, 107(Pt 8):2177-2189.
21. Goldstein J.L., Anderson R.G., Brown M.S. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 1979, 279:679-685.
22. Goldstein J.L., Brown M.S., Anderson R.G., Russell D.W., Schneider W.J. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu. Rev. Cell Biol. 1985, 1:1-39.
23. Gould G.W., Lippincott-Schwartz J. New roles for endosomes: from vesicular carriers to multi-purpose platforms. Nat. Rev. Mol. Cell Biol. 2009, 10:287-292.
24. Henne C., Schwenk F., Koch N., Moller P. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens. Immunology 1995, 84:177-182.
25. Hofmann M.W., Honing S., Rodionov D., Dobberstein B., von Figura K., Bakke O. The leucine-based sorting motifs in the cytoplasmic domain of the invariant chain are recognized by the clathrin adaptors AP1 and AP2 and their medium chains. J. Biol. Chem. 1999, 274:36153-36158.
26. Kleemann R., Grell M., Mischke R., Zimmermann G., Bernhagen J. Receptor binding and cellular uptake studies of macrophage migration inhibitory factor (MIF): use of biologically active labeled MIF derivatives. J. Interferon Cytokine Res. 2002, 22:351-363.
27. Kleemann R., Hausser A., Geiger G., Mischke R., Burger-Kentischer A., Flieger O., Johannes F.J., Roger T., Calandra T., Kapurniotu A., Grell M., Finkelmeier D., Brunner H., Bernhagen J. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000, 408:211-216.
28. Lagane B., Chow K.Y., Balabanian K., Levoye A., Harriague J., Planchenault T., Baleux F., Gunera-Saad N., Arenzana-Seisdedos F., Bachelerie F. CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. Blood 2008, 112:34-44.
29. Lakadamyali M., Rust M.J., Zhuang X. Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 2006, 124:997-1009.
30. Leng L., Metz C.N., Fang Y., Xu J., Donnelly S., Baugh J., Delohery T., Chen Y., Mitchell R.A., Bucala R. MIF signal transduction initiated by binding to CD74. J. Exp. Med. 2003, 197:1467-1476.
31. Lue H., Dewor M., Leng L., Bucala R., Bernhagen J. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell. Signal. 2011, 23:135-144.
32. Lue H., Kapurniotu A., Fingerle-Rowson G., Roger T., Leng L., Thiele M., Calandra T., Bucala R., Bernhagen J. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell. Signal. 2006, 18:688-703.
33. Lue H., Thiele M., Franz J., Dahl E., Speckgens S., Leng L., Fingerle-Rowson G., Bucala R., Luscher B., Bernhagen J. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 2007, 26:5046-5059.
34. Marchese A., Chen C., Kim Y.M., Benovic J.L. The ins and outs of G protein-coupled receptor trafficking. Trends Biochem. Sci. 2003, 28:369-376.
35. Marchese A., Paing M.M., Temple B.R., Trejo J. G protein-coupled receptor sorting to endosomes and lysosomes. Annu. Rev. Pharmacol. Toxicol. 2008, 48:601-629.
36. Matza D., Kerem A., Shachar I. Invariant chain, a chain of command. Trends Immunol. 2003, 24:264-268.
37. Meyer-Siegler K.L., Iczkowski K.A., Leng L., Bucala R., Vera P.L. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J. Immunol. 2006, 177:8730-8739.
38. Miaczynska M., Bar-Sagi D. Signaling endosomes: seeing is believing. Curr. Opin. Cell Biol. 2010, 22:535-540.
39. Miaczynska M., Pelkmans L., Zerial M. Not just a sink: endosomes in control of signal transduction. Curr. Opin. Cell Biol. 2004, 16:400-406.
40. Moldenhauer G., Henne C., Karhausen J., Moller P. Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments. Immunology 1999, 96:473-484.
41. Montesano R., Roth J., Robert A., Orci L. Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature 1982, 296:651-653.
42. Moser B., Loetscher P. Lymphocyte traffic control by chemokines. Nat. Immunol. 2001, 2:123-128.
43. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., Power C.A. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 2000, 52:145-176.
44. Nguyen M.T., Lue H., Kleemann R., Thiele M., Tolle G., Finkelmeier D., Wagner E., Braun A., Bernhagen J. The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. J. Immunol. 2003, 170:3337-3347.
45. Noels H., Bernhagen J., Weber C. Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis. Trends Cardiovasc. Med. 2009, 19:76-86.
46. Rot A., von Andrian U.H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 2004, 22:891-928.
47. Schober A., Bernhagen J., Thiele M., Zeiffer U., Knarren S., Roller M., Bucala R., Weber C. Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice. Circulation 2004, 109:380-385.
48. Schwartz V., Lue H., Kraemer S., Korbiel J., Krohn R., Ohl K., Bucala R., Weber C., Bernhagen J. A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett. 2009, 583:2749-2757.
49. Shi X., Leng L., Wang T., Wang W., Du X., Li J., McDonald C., Chen Z., Murphy J.W., Lolis E., Noble P., Knudson W., Bucala R. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 2006, 25:595-606.
50. Signoret N., Oldridge J., Pelchen-Matthews A., Klasse P.J., Tran T., Brass L.F., Rosenkilde M.M., Schwartz T.W., Holmes W., Dallas W., Luther M.A., Wells T.N., Hoxie J.A., Marsh M. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J. Cell Biol. 1997, 139:651-664.
51. Simons D., Grieb G., Hristov M., Pallua N., Weber C., Bernhagen J., Steffens G. Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment. J. Cell. Mol. Med. 2011, 15:668-678.
52. Son A., Kato N., Horibe T., Matsuo Y., Mochizuki M., Mitsui A., Kawakami K., Nakamura H., Yodoi J. Direct association of thioredoxin-1 (TRX) with macrophage migration inhibitory factor (MIF): regulatory role of TRX on MIF internalization and signaling. Antioxid. Redox Signal. 2009, 11:2595-2605.
53. Sorkin A., von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat. Rev. Mol. Cell Biol. 2002, 3:600-614.
54. Stern L.J., Potolicchio I., Santambrogio L. MHC class II compartment subtypes: structure and function. Curr. Opin. Immunol. 2006, 18:64-69.
55. Tarnowski M., Grymula K., Liu R., Tarnowska J., Drukala J., Ratajczak J., Mitchell R.A., Ratajczak M.Z., Kucia M. Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts. Mol. Cancer Res. 2010, 8:1328-1343.
56. Thelen M., Stein J.V. How chemokines invite leukocytes to dance. Nat. Immunol. 2008, 9:953-959.
57. Thomson A.W. The Cytokine Handbook 2003, Academic Press, New York, NY, USA.
58. Tran D., Carpentier J.L., Sawano F., Gorden P., Orci L. Ligands internalized through coated or noncoated invaginations follow a common intracellular pathway. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:7957-7961.
59. Vera P.L., Iczkowski K.A., Wang X., Meyer-Siegler K.L. Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association. PLoS ONE 2008, 3:e3898.
60. von Zastrow M., Sorkin A. Signaling on the endocytic pathway. Curr. Opin. Cell Biol. 2007, 19:436-445.
61. Wall D.A., Wilson G., Hubbard A.L. The galactose-specific recognition system of mammalian liver: the route of ligand internalization in rat hepatocytes. Cell 1980, 21:79-93.
62. Weber C., Schober A., Zernecke A. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1997-2008.
63. Xie L., Qiao X., Wu Y., Tang J. beta-Arrestin1 mediates the endocytosis and functions of macrophage migration inhibitory factor. PLoS ONE 2011, 6:e16428.
64. Zernecke A., Bernhagen J., Weber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation 2008, 117:1594-1602.
65. Zhang Y., Foudi A., Geay J.F., Berthebaud M., Buet D., Jarrier P., Jalil A., Vainchenker W., Louache F. Intracellular localization and constitutive endocytosis of CXCR4 in human CD34+ hematopoietic progenitor cells. Stem Cells 2004, 22:1015-1029.